The Skin Cancer Sessions: Highlights from ASCO 2021

VJOncology has assembled a panel of world-renowned skin cancer experts to examine and discuss the exciting advances in skin cancer presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.

In this exclusive podcast, James Larkin, MD, PhD, Royal Marsden Hospital, London, UK, is joined by Rodabe Amaria, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Ana Arance, MD, PhD, Hospital Clínic de Barcelona, Barcelona, Spain, and Paolo Ascierto, MD, National Tumor Institute, Milan, Italy.

Listen to this insightful roundtable discussion to learn about the latest clinical trial data in skin cancer, including updates in adjuvant pembrolizumab in the KEYNOTE-054 and S1404 trials, as well as neoadjuvant ipilimumab plus nivolumab in OpACIN-neo trial. Additional topics of discussion include long-term follow-up in the CheckMate 067 and COLUMBUS trials, relatlimab plus nivolumab in RELATIVITY-047, lenvatinib in the anti-PD-1 refractory space in LEAP-004, and much more.

The post The Skin Cancer Sessions: Highlights from ASCO 2021 appeared first on VJOncology.